Redwood Investments’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Redwood Investments’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-5,328	Closed	-$606K	–	129
2022 Q4	$606K	Sell	5,328 -127	-2%	-$10.5K	0.08%	96
2022 Q3	$338K	Sell	5,455 -102	-2%	-$7.13K	0.05%	103
2022 Q2	$443K	Sell	5,557 -70	-1%	-$6.63K	0.05%	108
2022 Q1	$592K	Buy	5,627 +3	+0.1%	+$292	0.06%	105
2021 Q4	$606K	Sell	5,624 -94	-2%	-$10.3K	0.05%	112
2021 Q3	$626K	Hold	5,718	–	–	0.05%	109
2021 Q2	$535K	Sell	5,718 -29,171	-84%	-$2.68M	0.04%	113
2021 Q1	$3.21M	Buy	34,889 +17,469	+100%	+$1.47M	0.28%	77
2020 Q4	$1.27M	Sell	17,420 -14,675	-46%	-$1.09M	0.11%	99
2020 Q3	$2.49M	Sell	32,095 -241,667	-88%	-$16.6M	0.21%	91
2020 Q2	$15.2M	Sell	273,762 -356,667	-57%	-$15.3M	1.35%	34
2020 Q1	$18.7M	Buy	+630,429	New	+$21.3M	2.2%	8
2019 Q4	–	Sell	-1,376,066	Closed	-$37.5M	–	138
2019 Q3	$37.5M	Buy	1,376,066 +77,270	+6%	+$2M	2.89%	1
2019 Q2	$31.2M	Buy	1,298,796 +35,743	+3%	+$907K	2.3%	1
2019 Q1	$33.4M	Buy	1,263,053 +199,888	+19%	+$4.74M	2.44%	1
2018 Q4	$20.8M	Buy	1,063,165 +68,807	+7%	+$1.35M	1.95%	3
2018 Q3	$19.5M	Sell	994,358 -320,791	-24%	-$6.1M	1.52%	10
2018 Q2	$21.8M	Sell	1,315,149 -4,932	-0.4%	-$75.2K	1.51%	11
2018 Q1	$18.7M	Buy	1,320,081 +402,610	+44%	+$5.95M	1.34%	21
2017 Q4	$13.4M	Buy	917,471 +572,085	+166%	+$8.04M	0.95%	51
2017 Q3	$4.38M	Sell	345,386 -160,204	-32%	-$2.04M	0.5%	93
2017 Q2	$6M	Buy	505,590 +21,827	+5%	+$272K	0.6%	82
2017 Q1	$7.15M	Buy	483,763 +24,377	+5%	+$395K	0.71%	71
2016 Q4	$7.43M	Sell	459,386 -24,970	-5%	-$453K	0.67%	64
2016 Q3	$8.78M	Buy	484,356 +230,310	+91%	+$4.5M	0.67%	52
2016 Q2	$4.18M	Buy	254,046 +56,999	+29%	+$922K	0.38%	77
2016 Q1	$3.27M	Buy	197,047 +85,365	+76%	+$1.49M	0.32%	78
2015 Q4	$2.42M	Buy	111,682 +34,008	+44%	+$662K	0.26%	63
2015 Q3	$1.54M	Buy	77,674 +33,157	+74%	+$1.05M	0.2%	79
2015 Q2	$1.55M	Buy	+44,517	New	+$1.36M	0.19%	100

Other funds holding HZNP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

DKCM

Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Redwood Investments's HZNP Position: Q1 2023 in Review

Redwood Investments sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q1 2023, closing a stake of 5,328 shares — an estimated $606K sold.

Redwood Investments first reported a position in HZNP in Q2 2015 and held it in 30 quarters. The position peaked at $37.5M in Q3 2019. 553 funds tracked by Wall St. Rank hold HZNP as of Q1 2023.

Redwood Investments reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q1 2023 after selling out during the quarter.
Redwood Investments sold 5,328 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q1 2023, an estimated $606K.
Redwood Investments first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q2 2015 and held it in 30 quarters.
Redwood Investments's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $37.5M in Q3 2019.
553 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q1 2023.

Based on Redwood Investments's 13F filing for Q1 2023, filed 24 Apr 2023.